ES2169061T3 - Vacuna vivas in ovo. - Google Patents

Vacuna vivas in ovo.

Info

Publication number
ES2169061T3
ES2169061T3 ES94117270T ES94117270T ES2169061T3 ES 2169061 T3 ES2169061 T3 ES 2169061T3 ES 94117270 T ES94117270 T ES 94117270T ES 94117270 T ES94117270 T ES 94117270T ES 2169061 T3 ES2169061 T3 ES 2169061T3
Authority
ES
Spain
Prior art keywords
live
ovo
microorganism
modified
modified microorganism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94117270T
Other languages
English (en)
Inventor
Peter John Coloe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2169061T3 publication Critical patent/ES2169061T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/826—Bacterial vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION RELATA GENERALMENTE A MICROORGANISMOS MODIFICADOS PARA USO COMO VACUNAS OVO INTERNAS PARA ESPECIES AVIARES. LAS VACUNAS OVO INTERNAS DE LA PRESENTE INVENCION SON UTILES POR INDUCIR INMUNIDAD ANTES O INMEDIATAMENTE DESPUES DE LA INCUBACION CONTRA UNA FORMA VIRULENTA DEL MICROORGANISMO MODIFICADO O UN MICROORGANISMO INMUNOLOGICAMENTE RELACIONADO AL MICROORGANISMOS MODIFICADO O UN ORGANISMO VIRULENTO O VIRUS PORTADOR DE UN ANTIGENICO DETERMINANTE EXPRESADO POR EL MICROORGANISMO MODIFICADO EN LA VACUNA INTERNA. LAS VACUNAS OVO INTERNAS SOMETIDAS SON PARTICULARMENTE EFICACES EN INCREMENTAR EL INDICE DE SUPERVIVENCIA DE LOS PAJAROS AVES DE CORRAL INCUBADOS NUEVAMENTE.
ES94117270T 1993-11-03 1994-11-02 Vacuna vivas in ovo. Expired - Lifetime ES2169061T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14720793A 1993-11-03 1993-11-03
CN94117813A CN1106299A (zh) 1993-11-03 1994-11-04 卵内活疫苗

Publications (1)

Publication Number Publication Date
ES2169061T3 true ES2169061T3 (es) 2002-07-01

Family

ID=36940636

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94117270T Expired - Lifetime ES2169061T3 (es) 1993-11-03 1994-11-02 Vacuna vivas in ovo.

Country Status (13)

Country Link
US (1) US6231871B1 (es)
EP (1) EP0650733B1 (es)
JP (1) JPH07206705A (es)
CN (1) CN1106299A (es)
AT (1) ATE211922T1 (es)
AU (1) AU7763294A (es)
CA (1) CA2134835C (es)
DE (1) DE69429646T2 (es)
DK (1) DK0650733T3 (es)
ES (1) ES2169061T3 (es)
NZ (1) NZ264845A (es)
PT (1) PT650733E (es)
ZA (1) ZA948643B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU223707B1 (hu) * 1995-06-07 2004-12-28 Pfizer Inc. Eimeria sporozoiták vagy merozoiták alkalmazása coccidiózis elleni in ovo vakcinázásra szolgáló vakcina előállítására
EP0831896B1 (en) * 1995-06-07 2001-06-27 Pfizer Inc. In ovo vaccination against coccidiosis
JP2000502257A (ja) * 1995-12-19 2000-02-29 アイオワ ステート ユニバーシティー リサーチ ファウンデーション，インコーポレーテッド ヘテロフィル適合化家禽用ワクチン
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
US6410222B1 (en) 1998-12-14 2002-06-25 Juridical Foundation The Chemosero-Therapeutic Research Institute In ovo vaccination of marek's disease type I virus
US6984378B1 (en) 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
PL203874B1 (pl) * 2000-01-20 2009-11-30 Martek Biosciences Corp Zastosowanie karmy zawierającej źródło kwasu tłuszczowego o długim łańcuchu, mającego co najmniej 20 atomów węgla, w karmieniu królików
ES2316492T3 (es) * 2000-11-16 2009-04-16 Intervet International Bv Vacuna contra la salmonella.
EP1421178B1 (en) 2001-08-30 2010-10-13 Embrex, Inc. Improved methods for producing oocysts
US7357935B2 (en) 2003-05-14 2008-04-15 Wyeth Avian E. coli vaccine for protection against colibacillosis
US7297338B2 (en) * 2003-05-14 2007-11-20 Wyeth Avian vaccine composition for the protection of poultry against disease and infection caused by E. coli and Salmonella
US20090297561A1 (en) * 2003-09-03 2009-12-03 Intralytix Method for vaccination of poultry by bacteriophage lysate bacterin
JP4602347B2 (ja) * 2003-12-03 2010-12-22 ファイザー・プロダクツ・インク 鳥類におけるカンピロバクターの卵内接種
CN1276076C (zh) * 2004-12-14 2006-09-20 华东理工大学 一种鳗弧菌野生毒株的无标记基因缺失减毒突变株及其应用
US20060196428A1 (en) * 2005-03-03 2006-09-07 Correa Rafael S Method for improving chick hatchability
AU2007245198B2 (en) * 2006-03-30 2010-08-12 Zoetis Services Llc Methods and compositions for vaccination of poultry
UA100370C2 (uk) 2006-12-11 2012-12-25 Мериал Лимитед Спосіб вакцинації птахів проти salmonella
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
CN101802173B (zh) * 2007-06-13 2014-09-24 联邦科学技术研究组织 调节禽类的生产性状
AR072976A1 (es) * 2008-08-08 2010-10-06 Wyeth Corp Virus de bronquitis infecciosa (ib) aislado, composicion de vacuna y metodo para preparar un virus de bronquitis infecciosa (ib) atenuado vivo
RU2679039C2 (ru) 2012-10-26 2019-02-05 Интервет Интернэшнл Б.В. Вызывающие перекрестный иммунитет вакцины против сальмонеллы
WO2023170057A1 (en) 2022-03-08 2023-09-14 Hipra Scientific, S.L.U. In ovo vaccine compositions against coccidiosis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2851006A (en) 1955-11-03 1958-09-09 Swift & Co Hatching of eggs
US3120834A (en) 1961-11-01 1964-02-11 Vineland Poultry Lab Method of introducing adjusvants into avian egg interiors
US3256856A (en) 1964-08-19 1966-06-21 Francis C Moore Method of introducing small controlled amounts of treatment materials into avian eggs
US5210035A (en) * 1980-05-19 1993-05-11 Board Of Trustees Of Leland Stanford Jr. University Non-reventing live vaccines
US4735801A (en) * 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
US4458630A (en) * 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
JPS61500663A (ja) * 1983-12-13 1986-04-10 コモンウエルス　サイエンテイフイツク　アンド　インダストリアル　リサ−チ　オ−ガナイゼイシヨン 感染性嚢病ウィルスワクチン
IL85980A (en) * 1987-04-16 1992-03-29 Embrex Inc Disease control in avian species by embryonal vaccination with a nonreplicating immunogen
US5206015A (en) 1989-06-05 1993-04-27 The United States Of America As Represented By The Secretary Of Agriculture Introduction of bacteria in ovo
DK0755684T3 (da) * 1989-10-02 2001-08-20 Univ Arkansas Vaccinekonjugat
FR2757061B1 (fr) * 1996-12-16 1999-03-26 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
US6048535A (en) * 1997-06-12 2000-04-11 Regents Of The University Of Minnesota Multivalent in ovo avian vaccine

Also Published As

Publication number Publication date
DE69429646D1 (de) 2002-02-21
JPH07206705A (ja) 1995-08-08
EP0650733B1 (en) 2002-01-16
CA2134835C (en) 2008-06-03
EP0650733A1 (en) 1995-05-03
DE69429646T2 (de) 2002-11-14
CA2134835A1 (en) 1995-05-04
AU7763294A (en) 1995-05-18
ATE211922T1 (de) 2002-02-15
US6231871B1 (en) 2001-05-15
DK0650733T3 (da) 2002-03-11
ZA948643B (en) 1995-07-07
CN1106299A (zh) 1995-08-09
NZ264845A (en) 1997-09-22
PT650733E (pt) 2002-06-28

Similar Documents

Publication Publication Date Title
ES2169061T3 (es) Vacuna vivas in ovo.
WO2000004919A3 (en) Live attenuated salmonella vaccines to control avian pathogens
ES2152292T3 (es) Vacuna para aves de corral que contiene el virus de la bronquitis infecciosa 4/91.
SE9003198D0 (sv) Fish vaccine comprising a virulent, invasive bacterium
Heddleston et al. Fowl cholera: immune response in turkeys
HUT65367A (en) Method for the preparation of chicken anaemia agent vaccine
ES2164074T3 (es) Vacunas de virus de la hepatitis a.
DK0626008T3 (da) Vaccine, der som en adjuvans indeholder acemannan
ES2098788T3 (es) Nueva bacteria que provoca enfermedades en las aves y vacuna derivada de esta bacteria.
Gross Escherichia coli as a complicating factor of Newcastle disease vaccination
Richey et al. The effect of congenital passive immunity levels on the response of chicks to Newcastle disease vaccination
EP0256792A3 (en) Vaccines for fowl colibacillosis
HU204439B (en) Process for producing living virus-vaccines against newcastle-disease and newcastle-disease and infective bronchitis and for producing virus of newcastle-disease
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
DE3361138D1 (en) Ozone inactivated organisms as vaccines
HU0100908D0 (en) Chicken anaemia viruses of low pathogenicity
SU661017A1 (ru) Штамм б-73
IE853109L (en) Vaccines against avian infectious bronchitis
Stone et al. Newcastle disease vaccination with beta-propiolactone-inactivated virus given intratracheally
DE69208854D1 (de) Impfstoff-Zubereitung zur Vorbeugung gegen bei Tieren durch Chlamydia psitacci verursachte Fehlgeburt
HUT37353A (en) Process for producing vaccine for treating infective laryngitis and trachitis of fowls
ES471766A1 (es) Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza
Saif-Edin IMMUNIZATION OF DUCKS AGAINST PASTEURELLA MULTOCIDA INFECTION BY AVIRULENT CU STRAIN 1-EFFICACY AND SAFETY OF THE VACCINE
TH62279A (th) วิธีการและวัคซีนสำหรับการจัดเตรียมการป้องกันในไข่ต่อต้านเทอร์คีไรโนทราคีไอติส

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 650733

Country of ref document: ES